Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease

Pediatrics

Volumn 107, Issue 2, 2001, Pages 217-221

  Murphy, Brendan P ^a   Inder, Terrie E ^b,c   Huppi, Petra S ^c,d   Warfield, Simon ^a   Zientara, Gary P ^a   Kikinis, Ron ^a   Jolesz, Ferenc A ^a   Volpe, Joseph J ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cerebral cortical gray matter; Dexamethasone; Prematurity; Volumetric 3D MRI

Indexed keywords

DEXAMETHASONE;

ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN GROWTH; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAY MATTER; HUMAN; IMAGE PROCESSING; LOW BIRTH WEIGHT; NERVE CELL DIFFERENTIATION; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; CEREBRAL CORTEX; CEREBROSPINAL FLUID; CHRONIC DISEASE; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; WEIGHT GAIN;

EID: 0035146199     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.2.217     Document Type: Article

References (25)

1. Outcomes of children of extremely low birth-weight and gestational age in the 1990's
2. Brain injury in the premature infant: Overview of clinical aspects, neuropathology, and pathogenesis
3. Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial
4. Clinical trials of postnatal corticosteroids: Inhaled and systemic
5. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age
6. Early dexamethasone therapy in preterm infants: A follow-up study
7. Dexamethasone for neonatal chronic lung disease
8. Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed
9. Cognitive deficit in premature infants
10. Gains and losses from dexamethasone for neonatal chronic lung disease
11. Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function
12. Early postnatal dexamethasone therapy is associated with increased incidence of cerebral palsy
13. Postnatal steroids: Short-term gain, long-term pain?
14. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants
15. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
16. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system
17. Perinatal glucocorticoids disrupt learning: A sexually dimorphic response
18. Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy
19. The therapeutic use of glucocorticoid hormones in the perinatal period. Potential neurological hazards
20. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain
21. Quantitative magnetic resonance imaging of brain development in premature and mature newborns
22. Periventricular white matter injury in the premature infant is associated with a reduction in cerebral cortical gray matter volume at term
23. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia
24. The CRIB (clinical risk index for babies) score: A total for assessing initial neonatal risk and comparing performance of neonatal intensive care units
25. CRIB and SNAP: Assessing the risk of death for preterm neonates